MiR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling

FEBS Journal

Volumn 280, Issue 18, 2013, Pages 4531-4538

  Guo, Yuwen ^a   Ying, Liang ^b   Tian, Ye ^a   Yang, Peiqian ^a   Zhu, Yichen ^a   Wang, Zhipeng ^a   Qiu, Feng ^b   Lin, Jun ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

bladder cancer; EZH2; miR 144; miRNA; Wnt

Indexed keywords

BETA CATENIN; MICRORNA; MICRORNA 144; TRANSCRIPTION FACTOR EZH2; UNCLASSIFIED DRUG; WNT PROTEIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER TISSUE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EZH2 GENE; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE REPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; WNT SIGNALING PATHWAY;

EID: 84883462991     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12417     Document Type: Article

References (30)

1. Lacey JV Jr, Devesa SS, &, Brinton LA, (2002) Recent trends in breast cancer incidence and mortality. Environ Mol Mutagen 39, 82-88.
2. Ying L, Chen Q, Wang Y, Zhou Z, Huang Y, &, Qiu F, (2012) Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition. Mol BioSyst 8, 2289-2294.
3. Egerod FL, Bartels A, Fristrup N, Borre M, Orntoft TF, Oleksiewicz MB, Brunner N, &, Dyrskjot L, (2009) High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression. BMC Cancer 9, 385.
4. Bo J, Yang G, Huo K, Jiang H, Zhang L, Liu D, &, Huang Y, (2011) microRNA-203 suppresses bladder cancer development by repressing bcl-w expression. FEBS J 278, 786-792.
5. Said N, Sanchez-Carbayo M, Smith SC, &, Theodorescu D, (2012) RhoGDI2 suppresses lung metastasis in mice by reducing tumor versican expression and macrophage infiltration. J Clin Invest 122, 1503-1518.
6. Kapinas K, Kessler CB, Ricks T, Gronowicz G, &, Delany AM, (2010) miR-29 modulates WNT signaling in human osteoblasts through a positive feedback loop. J Biol Chem 285, 25221-25231.
7. Mizuno Y, Yagi K, Tokuzawa Y, Kanesaki-Yatsuka Y, Suda T, Katagiri T, Fukuda T, Maruyama M, Okuda A, Amemiya T, et al,. (2008) miR-125b inhibits osteoblastic differentiation by down-regulation of cell proliferation. Biochem Biophys Res Commun 368, 267-272.
8. Wang T, &, Xu Z, (2010) miR-27 promotes osteoblast differentiation by modulating Wnt signaling. Biochem Biophys Res Commun 402, 186-189.
9. Zhang Y, Wei W, Cheng N, Wang K, Li B, Jiang X, &, Sun S, (2012) Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling. Hepatology 56, 1631-1640.
10. Zheng F, Liao YJ, Cai MY, Liu YH, Liu TH, Chen SP, Bian XW, Guan XY, Lin MC, Zeng YX, et al,. (2012) The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut 61, 278-289.
11. Zhang LY, Ho-Fun Lee V, Wong AM, Kwong DL, Zhu YH, Dong SS, Kong KL, Chen J, Tsao SW, Guan XY, et al,. (2013) MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN. Carcinogenesis 34, 454-463.
12. Iwaya T, Yokobori T, Nishida N, Kogo R, Sudo T, Tanaka F, Shibata K, Sawada G, Takahashi Y, Ishibashi M, et al,. (2012) Downregulation of miR-144 is associated with colorectal cancer progression via activation of mTOR signaling pathway. Carcinogenesis 33, 2391-2397.
13. Qi W, Chan H, Teng L, Li L, Chuai S, Zhang R, Zeng J, Li M, Fan H, Lin Y, et al,. (2012) Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation. Proc Natl Acad Sci USA 109, 21360-21365.
14. Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, Tempst P, Jones RS, &, Zhang Y, (2002) Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 298, 1039-1043.
15. Ren G, Baritaki S, Marathe H, Feng J, Park S, Beach S, Bazeley PS, Beshir AB, Fenteany G, Mehra R, et al,. (2012) Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer. Cancer Res 72, 3091-3104.
16. Wang H, Albadine R, Magheli A, Guzzo TJ, Ball MW, Hinz S, Schoenberg MP, Netto GJ, &, Gonzalgo ML, (2012) Increased EZH2 protein expression is associated with invasive urothelial carcinoma of the bladder. Urol Oncol 30, 428-433.
17. Wang X, Wang H, Bu R, Fei X, Zhao C, &, Song Y, (2012) Methylation and aberrant expression of the Wnt antagonist secreted Frizzled-related protein 1 in bladder cancer. Oncol Lett 4, 334-338.
18. Koch A, Waha A, Hartmann W, Hrychyk A, Schuller U, Wharton KA Jr, Fuchs SY, von Schweinitz D, &, Pietsch T, (2005) Elevated expression of Wnt antagonists is a common event in hepatoblastomas. Clin Cancer Res 11, 4295-4304.
19. Huang L, Luo J, Cai Q, Pan Q, Zeng H, Guo Z, Dong W, Huang J, &, Lin T, (2011) MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3. Int J Cancer 128, 1758-1769.
20. Chiyomaru T, Enokida H, Tatarano S, Kawahara K, Uchida Y, Nishiyama K, Fujimura L, Kikkawa N, Seki N, &, Nakagawa M, (2010) miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer 102, 883-891.
21. Chiang Y, Song Y, Wang Z, Chen Y, Yue Z, Xu H, Xing C, &, Liu Z, (2010) Aberrant expression of miR-203 and its clinical significance in gastric and colorectal cancers. J Gastrointest Surg 15, 63-70.
22. Noguchi S, Yasui Y, Iwasaki J, Kumazaki M, Yamada N, Naito S, &, Akao Y, (2013) Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways. Cancer Lett 328, 353-361.
23. Chang CJ, &, Hung MC, (2012) The role of EZH2 in tumour progression. Br J Cancer 106, 243-247.
24. Cheng AS, Lau SS, Chen Y, Kondo Y, Li MS, Feng H, Ching AK, Cheung KF, Wong HK, Tong JH, et al,. (2011) EZH2-mediated concordant repression of Wnt antagonists promotes beta-catenin-dependent hepatocarcinogenesis. Cancer Res 71, 4028-4039.
25. Wang L, Jin Q, Lee JE, Su IH, &, Ge K, (2010) Histone H3K27 methyltransferase Ezh2 represses Wnt genes to facilitate adipogenesis. Proc Natl Acad Sci USA 107, 7317-7322.
26. Wu Y, &, Zhou BP, (2008) New insights of epithelial-mesenchymal transition in cancer metastasis. Acta Biochim Biophys Sin (Shanghai) 40, 643-650.
27. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, et al,. (2005) Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33, e179.
28. Qin W, Shi Y, Zhao B, Yao C, Jin L, Ma J, &, Jin Y, (2010) miR-24 regulates apoptosis by targeting the open reading frame (ORF) region of FAF1 in cancer cells. PLoS One 5, e9429.
29. Tano K, Mizuno R, Okada T, Rakwal R, Shibato J, Masuo Y, Ijiri K, &, Akimitsu N, (2010) MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett 584, 4575-4580.
30. Xu N, Shen C, Luo Y, Xia L, Xue F, Xia Q, &, Zhang J, (2012) Upregulated miR-130a increases drug resistance by regulating RUNX3 and Wnt signaling in cisplatin-treated HCC cell. Biochem Biophys Res Commun 425, 468-472.